

Qiagen agrees to a $12 billion all-cash buyout by EQT. Analysts view the valuation discount as warranted given slower growth.
You can purchase shares of Qiagen (NYSE:QGEN) through any online brokerage.
Other companies in Qiagen’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Qiagen has a consensus price target of $47.04.
The stock price for Qiagen (NYSE: QGEN) is $50.495 last updated October 26, 2026 at 10:29 AM EDT.
There are no upcoming dividends for Qiagen.
Qiagen does not have any upcoming earnings scheduled.
There is no upcoming split for Qiagen.
Qiagen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between life sciences and molecular diagnostics applications. Qiagen generates nearly...